ArticleJournal of immunology (Baltimore, Md. : 1950)2019

C1s Inhibition by BIVV009 (Sutimlimab) Prevents Complement-Enhanced Activation of Autoimmune Human B Cells In Vitro.

Pavel A Nikitin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.